GLENMARK PHARMACEUTICALS
Back to All Ratios
|
GLENMARK PHARMACEUTICALS Last 5 Year EV/Core EBITDA History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| EV/Core EBITDA(x) | 17.83 | 12.95 | 8.48 | 5.93 | 7.80 |
What is the latest EV/Core EBITDA ratio of GLENMARK PHARMACEUTICALS ?
| Year | EV/Core EBITDA |
|---|---|
| Mar2025 | 17.83 |
| Mar2024 | 12.95 |
| Mar2023 | 8.48 |
| Mar2022 | 5.93 |
| Mar2021 | 7.80 |
How is EV/Core EBITDA of GLENMARK PHARMACEUTICALS Trending?
| Years | EV/Core EBITDA | % Change | |
|---|---|---|---|
| Mar2025 | 17.83 | 37.68 | |
| Mar2024 | 12.95 | 52.71 | |
| Mar2023 | 8.48 | 43.00 | |
| Mar2022 | 5.93 | -23.97 | |
| Mar2021 | 7.8 | - | |
Other Financial Ratios of GLENMARK PHARMACEUTICALS
| Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare EV/Core EBITDA ratio of peers of GLENMARK PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLENMARK PHARMACEUTICALS | ₹54,951.4 Cr | 5.8% | 5.6% | 27.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹439,378.0 Cr | 2.8% | 6.7% | 2.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹171,996.0 Cr | 1.9% | -0.5% | 6.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹125,959.0 Cr | 0.1% | 3.4% | 15.8% | Stock Analytics | |
| CIPLA | ₹123,666.0 Cr | 1.8% | -3.2% | 2.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹105,008.0 Cr | 2.7% | 0.4% | 3.4% | Stock Analytics | |
GLENMARK PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLENMARK PHARMACEUTICALS | 5.8% |
5.6% |
27.7% |
| SENSEX | 0.6% |
1.3% |
7% |
You may also like the below Video Courses